Cosmo Pharmaceuticals N.V. (SWX:COPN)

Switzerland · Delayed Price · Currency is CHF

61.20

-0.80 (-1.29%)

Jul 18, 2025, 5:30 PM CET

-12.45% (1Y)

Market Cap	980.12M
Revenue (ttm)	250.29M
Net Income (ttm)	125.00M
Shares Out	16.02M
EPS (ttm)	7.61
PE Ratio	8.04
Forward PE	20.13
Dividend	1.91 (3.12%)
Ex-Dividend Date	Jun 4, 2025

Volume	23,661
Average Volume	21,706
Open	62.00
Previous Close	62.00
Day's Range	60.50 - 62.20
52-Week Range	41.60 - 80.60
Beta	1.30
RSI	58.48
Earnings Date	Jul 23, 2025

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive... [Read more]

Industry Drug Manufacturers - General

Sector Healthcare

Founded 1997

Employees 322

Stock Exchange SIX Swiss Exchange

Ticker Symbol COPN

Full Company Profile